Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07218302 · ClinicalTrials.gov registry record · Phase 2
Eating Disorder Chatbot Optimization
A Phase 2 study, sponsored by Washington University School of Medicine.
- Not yet
- Registry status
- Phase 2
- Development phase
- 800
- Enrollment target
NCT07218302: Clinical Trial Phase 2 study, sponsored by Washington University School of Medicine.
NCT07218302 is a Phase 2 study that has not yet begun recruiting, run by Washington University School of Medicine. The registered enrollment target is 800 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (502% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07218302, a Phase 2 study, has not yet begun recruiting, sponsored by Washington University School of Medicine.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 800 participants
- Enrollment target
Study Summary
The purpose of this study is to optimize an automated digital chatbot intervention for adults with clinical or subclinical eating disorders.
Primary Outcome
The EDE-Q is a 28-item inventory derived from an ED diagnostic interview, which asks self-reported concerns with weight and shape, and engagement in ED behaviors, over the last 28 days. Each item is scored from 0-6, with 0 being "No days" and 6 being "Every day". An average is taken of all items participants respond to for a total global score (with possible scores ranging from 0 to 6), where higher scores indicate greater symptomology.
Interventions
- BEHAVIORAL Digital Chatbot Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2029-07-31 |
| Phase | Phase 2 |
What is known before NCT07218302 opens enrollment
NCT07218302 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (502% higher).
The record links to 0 conditions, and to 1 intervention - of which Digital Chatbot Program is the first listed.
NCT07218302 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07218302 about?
NCT07218302 is a clinical study titled "Eating Disorder Chatbot Optimization". The purpose of this study is to optimize an automated digital chatbot intervention for adults with clinical or subclinical eating disorders.
What is the current status of trial NCT07218302?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 800 participants. The study started on 2026-03-01. Estimated completion is 2029-07-31.
What interventions are being tested in trial NCT07218302?
The interventions under investigation include: Digital Chatbot Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07218302?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07218302's enrollment target sits among peer trials
800 37th of 2000 higher than 1,961 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI